Dr. Andrew Miller, Ph.D., has been appointed as a Class III director to the Board of Directors. The Board size was increased from six to seven members to accommodate the appointment. Dr. Miller will serve on the Nominating and Corporate Governance Committee (NCGC). Compensation includes an initial stock option grant valued at up to $400,000 and an annual cash retainer of $45,000 for board and committee service.